Literature DB >> 15625308

Bordetella dermonecrotic toxin exerting toxicity through activation of the small GTPase Rho.

Aya Fukui1, Yasuhiko Horiguchi.   

Abstract

Bordetella dermonecrotic toxin (DNT) is a virulence factor produced by bacteria belonging to the genus Bordetella. The toxin possesses novel transglutaminase activity that catalyzes polyamination or deamidation of the small GTPases of the Rho family. The modified GTPases loose their GTP hydrolyzing activity, function as a constitutive active molecule, and continuously transduce signals to downstream effectors, which mediate the consequent phenotypes of cells intoxicated by DNT. A dynamin-dependent endocytosis is required for the toxin to be internalized into cells although it is unlikely transported to deep organelles such as the Golgi apparatus or the ER. Several lines of evidence show that the toxin undergoes proteolytic cleavage by furin or furin-like protease probably in the early endosome, and then escapes into the cytoplasm to reach the GTPase.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15625308     DOI: 10.1093/jb/mvh155

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  8 in total

Review 1.  Recent insights into Pasteurella multocida toxin and other G-protein-modulating bacterial toxins.

Authors:  Brenda A Wilson; Mengfei Ho
Journal:  Future Microbiol       Date:  2010-08       Impact factor: 3.165

2.  Polyamines transduce the nongenomic, androgen-induced calcium sensitization in intestinal smooth muscle.

Authors:  María C González-Montelongo; Raquel Marín; José A Pérez; Tomás Gómez; Mario Díaz
Journal:  Mol Endocrinol       Date:  2013-09-03

3.  Association of Bordetella dermonecrotic toxin with the extracellular matrix.

Authors:  Aya Fukui-Miyazaki; Shigeki Kamitani; Masami Miyake; Yasuhiko Horiguchi
Journal:  BMC Microbiol       Date:  2010-09-25       Impact factor: 3.605

Review 4.  Potential opportunity in the development of new therapeutic agents based on endogenous and exogenous inhibitors of the proprotein convertases.

Authors:  Yannick Bontemps; Nathalie Scamuffa; Fabien Calvo; Abdel-Majid Khatib
Journal:  Med Res Rev       Date:  2007-09       Impact factor: 12.944

5.  Design of a Quantitative LC-MS Method for Residual Toxins Adenylate Cyclase Toxin (ACT), Dermonecrotic Toxin (DNT) and Tracheal Cytotoxin (TCT) in Bordetella pertussis Vaccines.

Authors:  Lisa Szymkowicz; Jeffery Gerard; Benjamin Messham; Wai Wan Vivian Tam; D Andrew James
Journal:  Toxins (Basel)       Date:  2021-10-28       Impact factor: 4.546

Review 6.  Pathogenicity and virulence of Bordetella pertussis and its adaptation to its strictly human host.

Authors:  Thomas Belcher; Violaine Dubois; Alex Rivera-Millot; Camille Locht; Françoise Jacob-Dubuisson
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

7.  Cystic Fibrosis Mice Develop Spontaneous Chronic Bordetella Airway Infections.

Authors:  R Darrah; T Bonfield; J J LiPuma; P Litman; C A Hodges; F Jacono; M Drumm
Journal:  J Infect Pulm Dis       Date:  2017-11-02

8.  An RNA thermometer dictates production of a secreted bacterial toxin.

Authors:  Christian Twittenhoff; Ann Kathrin Heroven; Sabrina Mühlen; Petra Dersch; Franz Narberhaus
Journal:  PLoS Pathog       Date:  2020-01-17       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.